Biotronik Se & Co. Kg
Clinical trials sponsored by Biotronik Se & Co. Kg, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Next-Gen heart defibrillators put to the test Results expected May 2027 (estimated)
- Heart device study aims to reduce painful shocks with smarter pacing Results expected May 2027 (estimated)
- Heart monitor study tracks Real-World performance Results expected May 2027 (estimated)
-
Heart device study aims to reduce painful shocks with smarter pacing
Disease control OngoingThis study compares two ways of programming implantable defibrillators (ICDs) in 398 Japanese patients. One group uses early, multiple bursts of rapid pacing (ATP) to stop dangerous heart rhythms, while the other uses a longer detection time before pacing. The goal is to see whic…
Sponsor: Biotronik SE & Co. KG • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New pacemaker system aims to improve heart rhythm therapy
Disease control OngoingThis study tests the safety and performance of a new pacemaker system (Amvia pacemaker and Solia CSP S lead) for people who need help with their heart's electrical system. The device is designed to pace a specific part of the heart's natural wiring to improve efficiency. 152 part…
Sponsor: Biotronik SE & Co. KG • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Heart failure device study aims to improve patient care
Knowledge-focused OngoingThis study follows over 3,000 heart failure patients who have a BIOTRONIC CRT device implanted. Researchers will track hospitalizations, deaths, and device issues over time to understand how well the devices work in real life. The goal is to find ways to improve treatment and dev…
Sponsor: Biotronik SE & Co. KG • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC